Dr. Lewis Cantley received the 2020 Dr. Paul Janssen Award for his discovery of PI-3-kinase (PI3K). His groundbreaking research led to the development of a new class of drugs called phosphoinositide-3 kinase inhibitors, and has revolutionized treatment for cancer, diabetes and autoimmune diseases.

In September, Dr. Cantley’s work was celebrated with the 2020 Dr. Paul Janssen Award Symposium at the New York Academy of Sciences. Learn more in an e-briefing from the event, available here.